The board, elected by ASCO’s member oncologists, is comprised of cancer physicians and clinical researchers who volunteer their time with ASCO.
Basch is a medical oncologist and distinguished professor in the UNC School of Medicine Division of Hematology/Oncology and a professor in the UNC Gillings School of Global Public Health. He also is director of UNC Lineberger’s cancer outcomes research program.
Basch’s clinical expertise is in prostate cancer, and his research focuses on patient-reported outcomes. A study presented at the 2017 ASCO Annual Meeting was featured during the meeting’s plenary session. In the study, Basch and his colleagues found that cancer patients who reported their symptoms to their cancer care providers using a web-based survey lived five months longer than those patients who used standard reporting methods. The median overall survival benefit data were drawn from a Memorial Sloan Kettering Cancer Center study that examined the impact of using computer surveys to communicate symptoms for patients with metastatic cancer.
He serves as an associate editor at the Journal of the American Medical Association and as co-chair of the cancer care delivery research committee of the Alliance cooperative group. He is a prior member of the NCI Board of Scientific Advisors. He also previously served as chair of both the ASCO Clinical Practice Guidelines Committee and the CancerLinQ Patient Reported Outcomes Committee, and was a member of the Quality of Care Council and the ASCO Annual Meeting Education Committee. He is currently a member of the Measures Steering Group, is on the editorial board of the Journal of Oncology Practice, and will be the faculty chair of the 2019 ASCO Quality of Care Symposium.